| Literature DB >> 34249080 |
Yaokun Li1, Xiangping Xu1, Ming Deng1, Xian Zou2, Zhifeng Zhao1, Sixiu Huang1, Dewu Liu1, Guangbin Liu1.
Abstract
The ovary is the most important reproductive organ in goats and directly affects the fecundity. Long non-coding RNAs (lncRNAs) are involved in the biological process of oocyte maturation. However, in the context of reproduction in goats, few studies have explored the regulation of lncRNAs. Therefore, we herein used the ovaries of high and low fecundity Leizhou black goats to identify differentially expressed lncRNAs (DElncRNAs) by high-throughput RNA sequencing; moreover, we analyzed the target genes of lncRNAs by functional annotation to explore the role of DElncRNAs in ovarian development. Twenty DElncRNAs were identified, of which six were significantly upregulated and 14 were significantly downregulated in high fecundity goats. Gene Ontology analyses suggested that MSTRG.3782 positively influences the expression of the corresponding gene API5, exerting regulative effects on the development of follicles, through which litter size might show variations. The target gene KRR1 of ENSCHIT00000001883 is significantly enriched in cell components, and ENSCHIT00000001883 may regulate cell growth and thus affect follicular development. Further, as per Kyoto Encyclopedia of Genes and Genomes pathway analyses, MSTRG.2938 was found to be significantly enriched, and we speculate that MSTRG.2938 could regulate ribosomal biogenesis in the pre-snoRNP complex as well as cell transformation in eukaryotes. Quantitative real-time PCR results were consistent with sequencing data. To conclude, our research results indicate that some lncRNAs play a key role in regulating follicle development and cell growth during goat' s ovarian development.Entities:
Keywords: fertility; goats; high-throughput nucleotide sequencing; litter size; long non-coding RNA; reproduction
Year: 2021 PMID: 34249080 PMCID: PMC8267794 DOI: 10.3389/fgene.2021.648158
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Quality control of RNA-seq data.
| Sample | Clean reads (bp) | Clean reads (%) | Q30 (bp) | Q30 (%) |
| LL_ovarian1 | 102,568,128 | 99.71 | 14,469,811,737 | 93.78 |
| LL_ovarian2 | 105,050,222 | 99.76 | 14,876,252,498 | 94.18 |
| LL_ovarian3 | 101,304,042 | 99.66 | 14,193,808,086 | 93.09 |
| LL_ovarian4 | 106,886,182 | 99.74 | 15,093,669,895 | 93.89 |
| LH_ovarian1 | 101,039,510 | 99.51 | 14,381,870,205 | 94.43 |
| LH_ovarian2 | 104,636,964 | 99.36 | 14,844,532,299 | 93.97 |
| LH_ovarian3 | 101,631,476 | 99.59 | 14,245,966,824 | 93.07 |
Statistics of the mapping result.
| Sample | Total-mapped(bp) | Multiol-mapped(bp) | Uniquely-mapped(bp) |
| LL_ovarian1 | 87,722,258(85.53%) | 3,401,453(3.88%) | 84,320,805(96.12%) |
| LL_ovarian2 | 94,045,775(89.52%) | 2,863,389(3.04%) | 91,182,386(96.96%) |
| LL_ovarian3 | 88,004,353(86.87%) | 2,413,301(2.74%) | 85,591,052(97.26%) |
| LL_ovarian4 | 95,760,551(89.59%) | 2,719,333(2.84%) | 93,041,218(97.16%) |
| LH_ovarian1 | 90,985,423(90.05%) | 2,200,033(2.42%) | 88,785,390(97.58%) |
| LH_ovarian2 | 93,646,857(89.50%) | 2,601,986(2.78%) | 91,044,871(97.22%) |
| LH_ovarian3 | 89,517,832(88.08%) | 2,404,052(2.69%) | 87,113,780(97.31%) |
FIGURE 1Analysis and validation of DElncRNAs in RNA-seq libraries. (A) Volcano map in analyzing DElncRNAs between high fecundity group and low fecundity group. The red plot represented up-regulated expression in high fecundity group; the blue plot represented down-regulated expression in high fecundity group. (B) Hierarchical clustering analysis of lncRNA expression profiles from libraries with 20 DElncRNAs. Data were expressed as FPKM. Red: relatively high expression; Green: relatively low expression. (C) qRT-PCR results pertaining to DElncRNAs were compared with RNA-seq data. Red: RNA-seq; blue: qRT-PCR.
Top 10 significantly enriched Gene Ontology (GO) terms of target genes of all long non-coding RNAs (lncRNAs).
| GO ID | GO name | Observed gene count | |
| GO:0001078 | Transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding | 25 | 8.11923E-09 |
| GO:0043565 | Sequence-specific DNA binding | 50 | 2.81848E-07 |
| GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 44 | 6.27029E-07 |
| GO:0003682 | Chromatin binding | 44 | 7.63455E-06 |
| GO:0001077 | Transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding | 32 | 1.22538E-05 |
| GO:0003700 | Transcription factor activity, sequence-specific DNA binding | 55 | 5.63408E-05 |
| GO:0044212 | Transcription regulatory region DNA binding | 21 | 0.000261987 |
| GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | 10 | 0.001142393 |
| GO:0005249 | Voltage-gated potassium channel activity | 10 | 0.001653743 |
| GO:0003705 | Transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding | 7 | 0.001653743 |
| GO:0045944 | Positive regulation of transcription from RNA polymerase II promoter | 79 | 4.46E-09 |
| GO:0001569 | Patterning of blood vessels | 13 | 1.33E-07 |
| GO:0060021 | Palate development | 20 | 6.08E-07 |
| GO:0051965 | Positive regulation of synapse assembly | 16 | 1.60E-06 |
| GO:0090090 | Negative regulation of canonical Wnt signaling pathway | 20 | 6.79359E-06 |
| GO:0045665 | Negative regulation of neuron differentiation | 14 | 1.19474E-05 |
| GO:0007411 | Axon guidance | 20 | 1.20265E-05 |
| GO:0042493 | Response to drug | 18 | 1.83209E-05 |
| GO:0042733 | Embryonic digit morphogenesis | 14 | 3.44706E-05 |
| GO:0042475 | Odontogenesis of dentin-containing tooth | 13 | 3.71271E-05 |
| GO:0005667 | Transcription factor complex | 32 | 2.15852E-07 |
| GO:0005634 | Nucleus | 232 | 6.64207E-07 |
| GO:0005887 | Integral component of plasma membrane | 74 | 0.003866795 |
| GO:0005615 | Extracellular space | 81 | 0.005325092 |
| GO:0030424 | Axon | 16 | 0.006989932 |
| GO:0005794 | Golgi apparatus | 50 | 0.007490282 |
| GO:0005783 | Endoplasmic reticulum | 45 | 0.022593322 |
| GO:0016592 | Mediator complex | 7 | 0.022693577 |
| GO:0009897 | External side of plasma membrane | 20 | 0.022811136 |
| GO:0071944 | Cell periphery | 5 | 0.031220242 |
FIGURE 2The GO analysis of target genes of lncRNAs. GO analysis of lncRNA-target genes according to biological process (BP), cell component (CC), and molecular function (MF); (A) The GO analysis of target genes of all lncRNAs, X-axis was P-value(-log10), Y-axis was the GO term. (B) The GO analysis of target genes of DElncRNAs, X-axis was P-value(-log10), Y-axis was the GO term.
Top 10 significantly enriched Gene Ontology (GO) terms of target genes of differentially expressed long non-coding RNAs (DElncRNAs).
| GO ID | GO name | Genes | |
| GO:1990226 | Histone methyltransferase binding | NOP56 | 0.0032 |
| GO:1990756 | Protein binding, bridging involved in substrate recognition for ubiquitination | ARRDC4 | 0.0041 |
| GO:0030515 | snoRNA binding | NOP56 | 0.0113 |
| GO:0017134 | Fibroblast growth factor binding | API5 | 0.0121 |
| GO:0001102 | RNA polymerase II activating transcription factor binding | TBXT | 0.0257 |
| GO:0033613 | Activating transcription factor binding | TBXT | 0.0415 |
| GO:0030674 | Protein binding, bridging | ARRDC4 | 0.047 |
| GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | TBXT | 0.0486 |
| GO:0060090 | Molecular adaptor activity | ARRDC4 | 0.0563 |
| GO:0001158 | Enhancer sequence-specific DNA binding | TBXT | 0.0602 |
| GO:0003257 | Positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | TBXT | 0.0017 |
| GO:1901228 | Positive regulation of transcription from RNA polymerase II promoter involved in heart development | TBXT | 0.0022 |
| GO:0003256 | Regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | TBXT | 0.003 |
| GO:2000270 | Negative regulation of fibroblast apoptotic process | API5 | 0.003 |
| GO:0060379 | Cardiac muscle cell myoblast differentiation | TBXT | 0.0043 |
| GO:0051443 | Positive regulation of ubiquitin-protein transferase activity | ARRDC4 | 0.0052 |
| GO:1901213 | Regulation of transcription from RNA polymerase II promoter involved in heart development | TBXT | 0.0052 |
| GO:0140112 | Extracellular vesicle biogenesis | ARRDC4 | 0.0056 |
| GO:2000269 | Regulation of fibroblast apoptotic process | API5 | 0.0056 |
| GO:0010002 | Cardioblast differentiation | TBXT | 0.0065 |
| GO:0031981 | Nuclear lumen | IER2, TBXT, API5, KRR1, NOP56, OIP5 | 0.0025 |
| GO:0070761 | Pre-snoRNP complex | NOP56 | 0.0036 |
| GO:0031974 | Membrane-enclosed lumen | IER2, TBXT, API5, KRR1, NOP56, OIP5 | 0.0036 |
| GO:0043233 | Organelle lumen | IER2, TBXT, API5, KRR1, NOP56, OIP5 | 0.0036 |
| GO:0070013 | Intracellular organelle lumen | IER2, TBXT, API5, KRR1, NOP56, OIP5 | 0.0036 |
| GO:0044428 | Nuclear part | IER2, TBXT, API5, KRR1, NOP56, OIP5 | 0.0041 |
| GO:0010369 | Chromocenter | OIP5 | 0.008 |
| GO:0005732 | Small nucleolar ribonucleoprotein complex | NOP56 | 0.0087 |
| GO:0016607 | Nuclear speck | API5, OIP5 | 0.0131 |
| GO:0000785 | Chromatin | TBXT, OIP5 | 0.0202 |
Top 10 significantly enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of target genes of all long non-coding RNAs.
| KEGG pathway | Number of genes | |
| TGF-beta signaling pathway | 19 | 3.48E-06 |
| Signaling pathways regulating pluripotency of stem cells | 25 | 7.62E-06 |
| Pathways in cancer | 49 | 1.28E-05 |
| Basal cell carcinoma | 14 | 3.25E-05 |
| Wnt signaling pathway | 23 | 3.61E-05 |
| HTLV-I infection | 34 | 4.89E-05 |
| Neuroactive ligand-receptor interaction | 35 | 9.47E-05 |
| Proteoglycans in cancer | 25 | 0.00199537 |
| Hippo signaling pathway | 20 | 0.004450684 |
| Transcriptional misregulation in cancer | 20 | 0.004786637 |
FIGURE 3The KEGG analysis of target genes of lncRNAs. (A) KEGG pathway analyses of target genes of all lncRNAs. KEGG enrichment was measured by rich factor, FDR and the number of genes enriched on this pathway. (B) KEGG pathway analyses of target genes of DElncRNAs. KEGG enrichment was measured by rich factor, FDR and the number of genes enriched on this pathway.
Top significantly enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of target genes of differentially expressed long non-coding RNAs.
| KEGG pathway | Number of genes | |
| Ribosome biogenesis in eukaryotes | 1 | 0.033754056 |
| Olfactory transduction | 1 | 0.261408061 |